Daniel Kazado, Director at IMMUNE PHARMACEUTICALS INC (IMNP), bought 161,377 shares at $0.19 ($31K) on 2016-12-16, disclosed to the SEC on 2016-12-20.
Open-market purchase of $31k IMNP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| IMNP | BUY | 2015-12-08 | $117K | — | Filing → |
| IMNP | BUY | 2015-09-16 | $74K | — | Filing → |
| IMNP | BUY | 2014-12-03 | $20K | — | Filing → |